Prelude Capital Management, LLC Harvard Bioscience Inc Transaction History
Prelude Capital Management, LLC
- $1.57 Billion
- Q3 2024
A detailed history of Prelude Capital Management, LLC transactions in Harvard Bioscience Inc stock. As of the latest transaction made, Prelude Capital Management, LLC holds 13,111 shares of HBIO stock, worth $28,057. This represents 0.0% of its overall portfolio holdings.
Number of Shares
13,111
Previous 13,111
-0.0%
Holding current value
$28,057
Previous $35,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding HBIO
# of Institutions
97Shares Held
30.6MCall Options Held
700Put Options Held
2.1K-
Black Rock Inc. New York, NY2.84MShares$6.09 Million0.0% of portfolio
-
Punch & Associates Investment Management, Inc. Edina, MN2.77MShares$5.93 Million0.44% of portfolio
-
Harvey Partners, LLC Tarrytown, NY2.72MShares$5.81 Million0.87% of portfolio
-
Amh Equity LTD2.39MShares$5.11 Million8.88% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.15MShares$4.61 Million0.0% of portfolio
About HARVARD BIOSCIENCE INC
- Ticker HBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 41,636,500
- Market Cap $89.1M
- Description
- Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as w...